GILEAD SCIENCES AND LAKEFRONT COMPLETE ACQUISITION OF OURO MEDICINES TO FURTHER EXPAND INFLAMMATION PIPELINE

Go back to GILEAD SCIENCES AND LAKEFRONT COMPLETE ACQUISITION OF OURO MEDICINES TO FURTHER EXPAND INFLAMMATION PIPELINE
Gilead Sciences (NASDAQ: GILD) Delayed: 125.70 +0.83 (0.66%)
Previous Close $124.87    52 Week High $108.63 
Open $126.63    52 Week Low $71.39 
Day High $126.63    P/E 69.45 
Day Low $124.44    EPS $1.81 
Volume 3,175,339